Product Description
Overall, the global infusion pump market was valued at $3.5 billion in 2023, a 3.1% increase from $3.4 billion in 2022. This is expected to increase over the forecast period at a CAGR of 2.6% to reach $4.2 billion. Currently, the global infusion pump market is dominated by Becton Dickinson (BD) and B. Braun.
Throughout this medical market research, we analyzed over 25 infusion pump companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for infusion pumps includes large-volume infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) infusion pumps, electronic ambulatory infusion pumps and disposable ambulatory infusion pumps..
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL INFUSION PUMP MARKET INSIGHTS
The global infusion pump market is experiencing growth. The rise in the elderly population is fueling the need for infusion pumps in healthcare assistance. As older individuals increasingly rely on extensive medication regimens, infusion pumps assume a crucial role in guaranteeing the precise and safe delivery of drugs. Senior patients, who may encounter difficulties in swallowing or require meticulous dosage management, derive substantial advantages from the accurate and controlled medication administration facilitated by infusion pumps. As the elderly demographic continues to expand, the importance of infusion pumps in catering to their specific medication requirements remains paramount.
GLOBAL INFUSION PUMP MARKET SHARE INSIGHTS
In 2023, Becton Dickinson (BD) emerged as the dominant force in the global infusion pump market. BD’s strategic acquisition of CareFusion, along with its IV therapy product line, solidified its position as a key player in the IV infusion pump sector. BD’s Alaris® product line stands out as a modular system, encompassing essential modules such as the Alaris™ PC Unit, Alaris™ Pump Module, Alaris™ Syringe Module, Alaris™ PCA Module, Alaris™ Auto-ID Module, and Alaris™ EtCO2, providing comprehensive solutions for healthcare settings.
Following closely behind, B. Braun secured the second spot in the global infusion pump market in 2023. The company demonstrated a commitment to innovation by enhancing its infusion pump product lines, with a particular focus on software enhancements and space-efficient designs. B. Braun’s Infusomat® volumetric pump has been globally available for a significant duration, and its latest iteration, the Infusomat® Space, is noteworthy. This compact, lightweight device is stackable, maximizing space utilization and enabling the placement of multiple pumps in minimal space.
The remainder of the market share was dispersed among various competitors, with each concentrating on specific segments, and only a few competing across the entire spectrum. Companies like BD and B. Braun enjoy a distinct advantage in this market due to their ability to offer a diverse range of infusion pumps, serving as convenient one-stop solutions for facilities seeking to expand their pump capabilities.
MARKET SEGMENTATION SUMMARY
- Large-Volume Pump Market – Segmented By:
- Care Setting: Hospital, Non-Hospital
- Syringe Pump Market – Segmented By:
- Hospital, Non-Hospital
- Patient-Controlled Analgesia Pump Market – Segmented By:
- Care Setting: Hospital, Non-Hospital
- Electronic Ambulatory Pump Market
- Disposable Ambulatory Pump
Global Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |